Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by HighPoint Advisor Group LLC

HighPoint Advisor Group LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.8% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 5,160 shares of the medical equipment provider’s stock after purchasing an additional 327 shares during the period. HighPoint Advisor Group LLC’s holdings in Intuitive Surgical were worth $2,693,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Norges Bank purchased a new stake in Intuitive Surgical during the fourth quarter valued at about $2,401,493,000. Proficio Capital Partners LLC grew its holdings in shares of Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after purchasing an additional 948,902 shares during the period. Raymond James Financial Inc. acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $313,769,000. Wilmington Savings Fund Society FSB raised its holdings in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares during the period. Finally, Vanguard Group Inc. lifted its position in Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after buying an additional 360,591 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $495.27 on Tuesday. The firm has a market cap of $176.40 billion, a PE ratio of 77.27, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm’s 50-day simple moving average is $554.33 and its 200-day simple moving average is $532.98.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last quarter. 0.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of research reports. Barclays raised their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Raymond James raised their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Citigroup upped their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Truist Financial dropped their target price on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a report on Monday, March 17th. Finally, Royal Bank of Canada upped their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.